Table 1.

Patient demographics and baseline disease characteristics

All patients (N = 36)
Median age, y (range)56.5 (23, 74)
Gender, n (%)
 Male21 (58.3)
 Female15 (41.7)
Race, n (%)
 Caucasian32 (88.9)
 African American2 (5.6)
 Asian1 (2.8)
 Other1 (2.8)
Karnofsky performance status, n (%)
 100%3 (8.3)
 90%21 (58.3)
 80%12 (33.3)
Cancer diagnosis, n (%)
 Colorectal11 (30.6)
 Sarcoma8 (16.7)
 Non–small cell lung2 (5.8)
 Mesothelioma1 (2.8)
 Pancreatic neuroendocrine1 (2.8)
 Hepatocellular1 (2.8)
 Ovarian1 (2.8)
 Pancreatic1 (2.8)
 Other12 (33.3)